why choose us

Clinical Trials Search

Showing 20,090 of 132,963 result(s)
Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients

Status: COMPLETED

Condition: Oncology

Interventions: Duloxetine 30mg ; day for 12 cycles (up to 6 months)

Date: 2022-08-13

Natural History and Pathogenesis of Alopecia in Children and Adults

Status: COMPLETED

Condition: Hair Loss

Interventions:

Date: 2022-08-13

Respired Gases in Patients Post Cardiac Surgery

Status: COMPLETED

Condition: Critically Ill

Interventions: To allow the OGA to acquire certain physiological data during the study it will be necessary to slightly vary the tension of oxygen and carbon dioxide

Date: 2022-08-13

Telehealth for Pain and Unhealthy Drinking Among PLWH

Status: Completed

Condition: HIV

Interventions: MCBMAP integrates motivational interviewing (MI) and cognitive-behavioral skill training interventions for unhealthy drinking with cognitive-behaviora

Date: 2022-08-13

Group-Based Telehealth Music Therapy Intervention for Patients With Dementia: A Pilot Study

Status: Completed

Condition: Behavioral and Psychiatric Symptoms of Dementia

Interventions: The format of the sessions may include: a greeting song to orient the participant to the start of the session; singing of 1-3 preferred;chosen so

Date: 2022-08-12

Atezolizumab for Idiopathic Pulmonary Fibrosis

Status: Completed

Condition: Idiopathic Pulmonary Fibrosis

Interventions: Atezolizumab 1200 mg administered via intravenous infusion every 3 weeks

Date: 2022-08-12

The Social Regulation of Threat-related Vigilance and Arousal

Status: NOT_YET_RECRUITING

Condition: Psychological Trauma, Historical

Interventions: social support is provided in the form of social touch (hand holding)

Date: 2022-08-12

Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation

Status: ACTIVE_NOT_RECRUITING

Condition: Allogeneic Hematopoietic Cell Transplantation

Interventions: Alemtuzumab (Campath®) is a recombinant DNA-derived humanized monoclonal antibody directed against CD52.
Alemtuzumab is produced in mammalian cel

Date: 2022-08-12

Family Model DSME in FBOs in the RMI

Status: Completed

Condition: Diabetes Mellitus, Type 2

Interventions: Participants assigned to this arm receive an intervention that includes a culturally adapted family model diabetes self-management education and suppo

Date: 2022-08-12

Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events

Status: Completed

Condition: Sepsis

Interventions: The study intervention is PRESS protocol training and educational delivered to EMS providers, followed by protocol implementation.
EMS providers

Date: 2022-08-12